1. Hartvig Honoré P . Eur J Hosp Pharm. 2013;20:206.
2. European Network for Health Technology Assessment (EUnetHTA). The HTA Core Model for Rapid Relative Effectiveness Assessments. Final version4.2. [Internet]. Copenhagen: EUnetHTA, 2015. http://meka.thl.fi/htacore/model/HTACoreModel_ForRapidREAs4.2.pdf. (Accessed Apr 2018).
3. European Network for Health Technology Assessment (EUnetHTA). Comparators & Comparisons. Criteria for the choice of the most appropriate comparator(s).Summary of current policies and best practice recommendations. Final version [Internet]. Copenhagen: EUnetHTA, 2013. http://www.eunethta.eu/sites/5026.fedimbo.belgium.be/files/Choice_of_comparator.pdf. (Accessed Apr 2018).
4. European Network for Health Technology Assessment (EUnetHTA). Comparators & Comparisons. Direct and indirect comparisons. Final version [Internet]. Copenhagen: EUnetHTA, 2013. http://www.eunethta.eu/sites/5026.fedimbo.belgium.be/files/Direct%20and%20indirect%20comparisons.pdf. (Accessed Apr 2018).
5. European Network for Health Technology Assessment (EUnetHTA). Endpoints used in relative effectiveness assessment of pharmaceuticals: Clinical Endpoints. Final version [Internet]. Copenhagen: EUnetHTA, 2013. http://www.eunethta.eu/sites/5026.fedimbo.belgium.be/files/Clinical%20endpoints.pdf. (Accessed Apr 2018).